Headline
The latest stories from AHA Today.
Leaders of the Senate Health, Education, Labor, and Pensions Committee released for comment until Feb. 4 a discussion draft of bipartisan legislation to strengthen the nation’s public health and medical preparedness and response systems in the wake of the COVID-19 pandemic.
Amid a resurgent COVID-19 and annual flu season, the AHA has released new resources that hospitals and health systems can use to encourage communities to stay healthy and protect themselves.
Based on recent data on omicron variant susceptibility to monoclonal antibodies, the Food and Drug Administration revised its emergency use authorizations for the combination therapies bamlanivimab and etesevimab and REGEN-COV (casirivimab and imdevimab) to exclude geographic regions where the…
The Health Resources and Services Administration will distribute $2 billion in a second wave of Provider Relief Fund “Phase 4” payments to providers who experienced revenue losses and expenses related to the COVID-19 pandemic based on changes in operating revenues and expenses from July 1, 2020, to…
The AHA asked the Health Resources and Services Administration to delay by at least one year the effective withdrawal date for Health Professional Shortage Areas designated as “proposed for withdrawal,” expressing concerns about the “extremely large numbers” of areas the agency proposes to end…
Nearly 200 House members are urging White House COVID-19 Response Team Coordinator Jeffrey Zients to investigate reports that nurse staffing agencies are taking advantage of the COVID-19 pandemic to increase their profits at the expense of patients and the hospitals that treat them.
The AHA hosted a press call with hospital leaders highlighting the urgent need for additional congressional relief to address the national health care workforce emergency and other challenges facing the field as a result of the COVID-19 pandemic. T
Hospital leaders and clinicians will join experts from the Centers for Disease Control and Prevention, AHA and American College of Obstetricians and Gynecologists Jan. 26 to discuss how health care professionals can work with their patients and communities to build trust in the safety and efficacy…
The Centers for Medicare & Medicaid Services will host a conference call for health care providers Jan. 26 at 1 p.m. ET on the balance billing provisions of the No Surprises Act.
The Food and Drug Administration expanded the approved uses for Vekury (remdesivir) to include non-hospitalized patients aged 12 and older who test positive for SARS-CoV-2, weigh at least 88 pounds and are at high risk of progressing to severe COVID-19.